Loading clinical trials...

Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT03341078

Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users

Addiction to methamphetamine is a serious health problem in the United States. Right now, there are no medications that a doctor can give someone to help them stop using methamphetamine. More research...

Lead sponsor: VA Office of Research and Development•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGPhase 3

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

NCT06233799 · Methamphetamine-dependence, Methamphetamine Abuse

RECRUITINGNA

Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives

NCT04927143 · Opioid-use Disorder, Cocaine Use Disorder, and more

RECRUITING

Role of Pavlovian Mechanisms for Control Over Substance Use

NCT06701487 · Alcohol Use Disorder (AUD), Alcoholism, and more

Active Not RecruitingNA

MHealth Incentivized Adherence Plus Patient Navigation

NCT06027814 · Opioid Use Disorder, Medication Adherence, and more

COMPLETEDNA

Contingency Management for PrEP Adherence and/or Methamphetamine Use

NCT04563962 · Methamphetamine-dependence, HIV-1-infection

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 2, 2026Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment176

Start dateMay 2019

Last updatedFeb 2, 2026

Condition

Methamphetamine-dependence

Locations shown

VA Portland Health Care System, Portland, OR

Portland, Oregon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions